Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2012, Article ID 368687, 5 pages
Clinical Study

Treatment Adherence with Early Prescription of Long-Acting Injectable Antipsychotics in Recent-Onset Schizophrenia

SM 13, Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, 75014 Paris, France

Received 5 December 2011; Revised 20 January 2012; Accepted 29 January 2012

Academic Editor: Robin A. Emsley

Copyright © 2012 Annie Viala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Borah Kim, Sang-Hyuk Lee, Yen Kuang Yang, Jong-Il Park, and Young-Chul Chung, “Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons,” Schizophrenia Research and Treatment, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • J.-M. Azorin, “Guidelines sur les antipsychotiques atypiques d’action prolongée (APAPs) dans les premiers épisodes psychotiques,” L'Encéphale, vol. 39, pp. S121–S123, 2013. View at Publisher · View at Google Scholar
  • Yoong Lee, Nam-Young Lee, Tak Youn, Yong-Seoung Choi, Yong-Sik Kim, and In-Won Chung, “The Preference Survey for Long-Acting Injectable Antipsychotics of Community-Dwelling Patients with Schizophrenia and their Caregivers,” Korean Journal of Schizophrenia Research, vol. 16, no. 1, pp. 14, 2013. View at Publisher · View at Google Scholar
  • Nam Young Lee, Se Hyun Kim, Seong Jin Cho, Young-Cho Chung, In Kwa Jung, Chang Yoon Kim, Duk Ho Kim, Dong Geun Lee, Yo Han Lee, Weon Jeong Lim, Young Suk Na, Sang Eun Shin, Jong-Min Woo, Jin Sang Yoon, Bo-Hyun Yoon, Yong Min Ahn, and Yong Sik Kim, “A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea,” International Clinical Psychopharmacology, vol. 29, no. 5, pp. 279–287, 2014. View at Publisher · View at Google Scholar
  • Sofia Brissos, Miguel Ruiz Veguilla, David Taylor, and Vicent Balanzá-Martinez, “The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal,” Therapeutic Advances in Psychopharmacology, vol. 4, no. 5, pp. 198–219, 2014. View at Publisher · View at Google Scholar
  • Dong-Jing Fu, Cynthia A. Bossie, Jennifer K. Sliwa, Yi-Wen Ma, and Larry Alphs, “Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison,” International Clinical Psychopharmacology, vol. 29, no. 1, pp. 45–55, 2014. View at Publisher · View at Google Scholar
  • Bianca-Stephanie Popp, Marinela Minodora Manea, and Madalina Oana Moraru, “Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication.,” Clujul medical (1957), vol. 87, no. 2, pp. 109–12, 2014. View at Publisher · View at Google Scholar
  • Georgia L. Stevens, Gail Dawson, and Jacqueline Zummo, “Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia,” Early Intervention in Psychiatry, 2015. View at Publisher · View at Google Scholar
  • Marc De Hert, Jan Sermon, Paul Geerts, Kristof Vansteelandt, Joseph Peuskens, and Johan Detraux, “The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics,” CNS Drugs, 2015. View at Publisher · View at Google Scholar
  • Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon, and David Castle, “Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region,” Asia-Pacific Psychiatry, vol. 8, no. 2, pp. 154–171, 2016. View at Publisher · View at Google Scholar
  • Sarah Lytle, Molly McVoy, and Martha Sajatovic, “Long-Acting Injectable Antipsychotics in Children and Adolescents,” Journal of Child and Adolescent Psychopharmacology, 2017. View at Publisher · View at Google Scholar
  • Maral DerSarkissian, Patrick Lefebvre, Kruti Joshi, Brianne Brown, Marie-Hélène Lafeuille, Rachel H. Bhak, Michael Hellstern, Priyanka Bobbili, Brian Shiner, Antoine C. El Khoury, and Yinong Young-Xu, “Health Care Resource Utilization and Costs Associated with Transitioning to 3-Month Paliperidone Palmitate Among US Veterans,” Clinical Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Erika N. Titus-Lay, Elayne D. Ansara, Alex N. Isaacs, and Carol A. Ott, “Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis,” Mental Health Clinician, vol. 8, no. 2, pp. 56–62, 2018. View at Publisher · View at Google Scholar